abagovomab 32
abciximab 30
abituzumab 22
abrilumab 19
actoxumab 18
adalimumab 18
aducanumab 11
afasevikumab 17
alacizumab_pegol 13
alemtuzumab 22
alirocumab 18
amatuximab 37
andecaliximab 20
anifrolumab 22
anrukinzumab 18
aprutumab 15
aprutumab_ixadotin 15
arcitumomab 24
ascrinvacumab 7
atezolizumab 16
atinumab 15
avelumab 14
basiliximab 28
bavituximab 37
begelomab 24
benralizumab 25
bevacizumab_beta 24
bezlotoxumab 18
bimagrumab 13
bleselumab 14
blinatumomab 34
blosozumab 28
bococizumab 17
brazikumab 15
brentuximab_vedotin 27
briakinumab 16
brodalumab 12
brolucizumab 27
brontictuzumab 25
burosumab 17
cabiralizumab 25
camrelizumab 14
canakinumab 24
cantuzumab_ravtansin 46
carlumab 14
carotuximab 30
cergutuzumab_amunaleukin2 24
cergutuzumab_amunaleukin 24
certolizumab_pegol 25
cetiximab 46
citatuzumab_bogatox 27
cixutumumab 24
clivatuzumab_tetraxetan 22
codrituzumab 31
conatumumab 9
concizumab 33
crenezumab 20
crizanlizumab 25
crotedumab 20
dacetuzumab 21
daclizumab 10
dalotuzumab 37
dapirolizumab_pegol 25
daratumumab 14
dectrekumab 9
demcizumab 22
denosumab 10
depatuxizumab 21
depatuxizumab_mafodotin 21
dezamizumab 18
dinutuximab 36
diridavumab 18
domagrozumab 15
drozitumab 14
duligotuzumab 20
durvalumab 10
dusigitumab 14
efalizumab 30
efungumab 29
eldelumab 14
elezanumab 19
elgemtumab 11
elotuzumab 17
emactuzumab 19
emapalumab 25
emibetuzumab 16
enavatuzumab 24
enfortumab_vedotin 13
enoblituzumab 18
enokizumab 22
enoticumab 17
ensituximab 31
eptinezumab 18
erenumab 18
etaracizumab 18
etrolizumab 22
evinacumab 21
evolocumab 14
farletuzumab 14
fasinumab 21
fezakinumab 16
fibatuzumab 11
ficlatuzumab 19
firivumab 33
flanvotumab 18
fletikumab 22
foralumab 10
foravirumab 13
fremanezumab 29
fresolimumab 17
fulranumab 19
futuximab 28
galcanezumab 18
ganitumab 26
gantenerumab 11
gemetuzumab 25
gemtuzumab2 25
gemtuzumab 23
gevokizumab 24
girentuximab 31
glembatumumab 16
glembatumumab_vedotin 16
guselkumab 23
ibalizumab 24
ibritumomab 28
icrucumab 9
idarucizumab 36
ifabotuzumab 11
imalumab 17
imgatuzumab 19
inclacumab 17
indatuximab_ravtansin 33
indusatumab 15
inebilizumab 29
intetumumab 13
iodine_girentuximab 29
ipilimumab 3
iratumumab 13
isatuximab 36
itolizumab 27
ixekizumab 31
labetuzumab_govitecan 20
lambrolizumab 27
lampalizumab 23
lanadelumab 18
landogrozumab 18
laprituximab 23
lebrikizumab 35
lendalizumab 22
lenzilumab 15
lifastuzumab_vedotin 25
ligelizumab 22
lilotomab 34
lirilumab 21
lodelcizumab 16
lokivetmab 25
lorvotuzumab_mertansin 27
lucatumumab 27
lumretuzumab 16
lupartumab 13
lutikizumab 21
margetuximab 33
milatuzumab 42
mirvetuximab 33
mirvetuximab_soravtansin 33
modotuximab 37
mogamulizumab 36
monalizumab 16
motavizumab 33
moxetumomab_pasudotox 32
namilumab 16
naratuximab 25
naratuximab_emtansin 25
narnatumab 15
navicixizumab2 27
navicixizumab 23
navivumab 36
necitumumab 10
nemolizumab 24
nesvacumab 14
nivolumab 12
obiltoxaximab 21
obinutuzumab 35
ocaratuzumab 26
ofatumumab 18
olaratumab 19
olokizumab 25
omalizumab 20
onartuzumab 22
ontuxizumab 22
opicinumab 14
orticumab 15
otelixizumab 38
oxelumab 12
ozanezumab 31
pamrevlumab 11
panobacumab 30
parsatuzumab 25
pasotuxizumab 23
pateclizumab 14
patritumab 18
pembrolizumab 27
perakizumab 21
pidilizumab 19
pinatuzumab_vedotin 19
plozalizumab 33
pogalizumab 22
polatuzumab_vedotin 22
ponezumab 37
prezalumab 14
pritoxaximab 30
quilizumab 21
racotumomab 28
radretumab 14
ralpancizumab 20
ramucirumab 14
ranevetmab 27
ranibizumab 24
refanezumab 25
remtolumab 18
rilotumumab 18
rinucumab 18
risankizumab 34
rituximab 20
rivabazumab 17
robatumumab 20
roledumab 32
romosozumab 20
rontalizumab 19
rosmantuzumab 21
rozanolixizumab 22
sacituzumab 28
sacituzumab_govitecan 28
samalizumab 22
sapelizumab 22
sarilumab 16
secukinumab 14
seribantumab 17
setoxaximab 43
sifalimumab 9
siltuximab 25
simtuzumab 26
sirukumab 13
solanezumab 26
solitomab 24
stamulumab 16
suptavumab 22
suvizumab 20
tabalumab 10
tadocizumab 14
tamtuvetmab 30
tanezumab 21
tarextumab 11
tavolixizumab 18
telisotuzumab 26
teplizumab 21
tesidolumab 20
tezepelumab 22
tigatuzumab 17
tildrakizumab 19
timolumab 15
tisotumab 14
tosatoxumab 37
tositumomab 28
tralokinumab 23
trastuzumab 22
tregalizumab 24
trevogrumab 13
ublituximab 29
urelumab 18
ustekinumab 27
utomilumab 27
vadastuximab 23
vadastuximab_talirin 23
vandortuzumab_vedotin 15
vantictumab 21
vanucizumab2 24
vanucizumab 26
varlilumab 13
vatelizumab 21
vedolizumab 26
veltuzumab 15
vesencumab 12
vorsetuzumab 22
vorsetuzumab_mafodotin 22
vunakizumab 33
xentuzumab 18
zatuximab 37
